Biopharmaceutical Manufacturing, Upstream, Downstream …
Biopharmaceutical Manufacturing, Upstream, Downstream processing news. News and analysis on the clinical development and manufacture of large molecule drugs. Synaffix and BigHat …
GE Healthcare Life Sciences becomes Cytiva
Apr 1, 2020 · GE Healthcare Life Sciences completes transition into Cytiva. As Danaher’s $21bn acquisition completes, GE Life Sciences rebrands to ‘Cytiva’ and, with the COVID-19 …
New wave of potential therapies to bring ‘paradigm shift’ in COPD …
Mar 25, 2024 · According to data and analytics firm GlobalData, this new wave of potential therapies will bring a shift in the treatment paradigm for COPD. The company predicts total …
Building a biotech hub: Switzerland focuses on mRNA, CGT and …
Sep 8, 2021 · There are 314 biotech companies in Switzerland: broken down into 251 developers and 63 suppliers. Swiss life science exports were valued at CHF 99.1bn ($108bn USD) in …
Kyverna Therapeutics’ CAR-T cell therapy shows promise against ...
Jun 10, 2024 · Kyverna Therapeutics has unveiled compelling new data for its CAR T-cell therapy, KYV-101, which may revolutionize the treatment of autoimmune diseases. In a landmark study …
Pharma and biopharma outsourcing strategies need to use an …
Oct 26, 2022 · But a new CPhI report on 'The Future of Outsourcing' advises against this approach. “Traditionally, outsourcing strategies were designed to help secure next stage …
US pharma hubs: The rising stars to watch
May 4, 2022 · It picks out Texas, Los Angeles and Chicago as among the hubs to watch, while there's also plenty of activity in Washington and North Carolina. Texas’ scale, workforce and …
Transfer of Marketing Authorisation: Mergers, mega-deals and the ...
May 23, 2023 · BPR: What is a Marketing Authorisation Transfer and what does it have to do with mergers and acquisitions in the biopharma industry? A Marketing Authorisation Transfer …
BMS achieves FDA approval for schizophrenia drug Cobenfy
Oct 1, 2024 · Bristol Myers Squibb (BMS) acquired Karuna Therapeutics, the developer of KarXT, in a deal worth US $14.0 billion in equity value that completed earlier this year. The deal has …
Moderna announces new vaccine candidates against Lyme disease …
Apr 12, 2023 · Pic:getty/peddlalankarameshbabu. Moderna has announced new mRNA vaccine development programs: with the Lyme disease candidate representing an expansion of the …